MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-1.35B
↓ 560% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-203.79M
Historical baseline
PeriodValueYoY Change
TTM$-1.35B-13976.9%
2024$-9.56M+39.7%
2023$-15.84M+17.2%
2022$-19.12M-46.2%
2021$-13.08M-55.1%
2020$-8.43M+45.1%
2019$-15.37M-